Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer

Abstract Background Interstitial lung abnormalities (ILAs) are known to be a risk of drug‐induced pneumonitis. However, there are few reports on the relationship between ILAs and immune checkpoint inhibitor‐related interstitial lung disease (ICI‐ILD). We retrospectively investigated the clinical sig...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Daiki Murata, Koichi Azuma, Goushi Matama, Yoshiaki Zaizen, Norikazu Matsuo, Kenta Murotani, Takaaki Tokito, Tomoaki Hoshino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-01-01
coleção:	Thoracic Cancer
Assuntos:	ICI‐ILD ILA NSCLC PD‐1 inhibitor
Acesso em linha:	https://doi.org/10.1111/1759-7714.14718
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!